PyInvesting

Market research

GMED Globus Medical

NYSE USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
12B
P/E ratio
22.23
Analyst target
103.2308
Dividend yield
Not available
Beta
0.95

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Globus Medical, Inc is currently in a long term uptrend where the price is trading 23.8% above its 200 day moving average.

From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.9.

Globus Medical, Inc's total revenue rose by 10.3% to $233M since the same quarter in the previous year.

Its net income has increased by 16.3% to $53M since the same quarter in the previous year.

Finally, its free cash flow grew by 71.7% to $66M since the same quarter in the previous year.

Based on the above factors, Globus Medical, Inc gets an overall score of 5/5.